Merit Medical Announces Preliminary Unaudited Revenue for the Year Ended December 31, 2024 and Plans to Announce Fourth Quarter and Year End 2024 Results and Issue Fiscal Year 2025 Guidance on February 25, 2025

Core Viewpoint - Merit Medical Systems, Inc. reported preliminary unaudited revenue for the year ended December 31, 2024, in the range of approximately $1.355 to$1.357 billion, indicating a projected increase of about 7.7% to 7.9% compared to the previous year [2][8]. Financial Performance - The preliminary constant currency revenue for the year ended December 31, 2024, increased by approximately 8.4% to 8.6% compared to the prior year [2][8]. - The preliminary unaudited revenue for 2024 is estimated to be between $1.355 billion and$1.357 billion, with a year-over-year increase of 7.7% to 7.9% [8][10]. Upcoming Announcements - Merit plans to announce its financial results for the quarter and year ended December 31, 2024, and provide fiscal year 2025 guidance on February 25, 2025 [3][8]. - An investor conference call is scheduled for the same day at 5:00 p.m. Eastern [3][4]. Non-GAAP Financial Measure - The company uses a non-GAAP financial measure of constant currency revenue to provide insights into underlying business trends and performance, which may be useful for period-over-period comparisons [5][6]. - The constant currency revenue is adjusted for foreign exchange rates and hedging transactions, reflecting a more accurate performance measure [6][10].